Search

everythinglearnresearchcommunity

for

Search:↓

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Plant extracts can help prevent hair loss and promote hair growth.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Four natural compounds were found to promote hair growth effectively.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Hydrogel with M2-derived exosomes improves wound healing by slowly releasing exosomes that help reduce inflammation and promote tissue repair.

Injecting platelet-rich plasma during hair transplant surgery improves hair regrowth rate, speeds up skin recovery, and enhances hair quality.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Atopic dermatitis increases the risk of some autoimmune diseases.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Glycosaminoglycans help heal wounds but aren't yet ready for clinical use.

Tiny fat-derived particles can help repair soft tissues by changing immune cell types.

miR-199a-3p controls hair growth and is linked to alopecia areata.